US Dollar vs MXN

Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.

Regístrate

BNTX BioNTech SE

86.04

-0.36 (-0.42%)

Última actualización: 14:09:18

Retrasado por 15 minutos

Pfizer/ BioNTech win European backing to relax storage requirement of COVID-19 shot

To read the full story on Seeking Alpha, click here.

BioNTech (NASDAQ:BNTX)
Gráfica de Acción Histórica
De Mar 2024 a Abr 2024

Haga Click aquí para más Gráficas BioNTech.

BioNTech (NASDAQ:BNTX)
Gráfica de Acción Histórica
De Abr 2023 a Abr 2024

Haga Click aquí para más Gráficas BioNTech.

Noticias sobre BioNTech SE BNTX

Three-year Phase 1 Follow-Up Data for mRNA-based Individualized Immunotherapy Candidate Show Persistence of Immune Response and Delayed Tumor Recurrence in Some Patients with Resected Pancreatic Cancer
Domingo 7 de Abril 2024 (2 semanas hace) • GlobeNewswire Inc.

Apple Pre-Market Drop Due to Antitrust Threats, Surprising Profit Boosts Micron Shares, and Latest Market Updates
Jueves 21 de Marzo 2024 (4 semanas hace) • IH Market News

U.S. Index Futures Trade Sideways Amid Anticipation of Fed’s Policy Update; Oil Prices Dip
Miércoles 20 de Marzo 2024 (4 semanas hace) • IH Market News

BioNTech Announces Fourth Quarter and Full Year 2023 Financial Results and Corporate Update
Miércoles 20 de Marzo 2024 (4 semanas hace) • GlobeNewswire Inc.

BioNTech Announces Appointment of Annemarie Hanekamp to Management Board as Chief Commercial Officer
Miércoles 20 de Marzo 2024 (4 semanas hace) • GlobeNewswire Inc.

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Lunes 11 de Marzo 2024 (1 mes hace) • Edgar (US Regulatory)

BioNTech to Present Clinical Data Updates for Personalized mRNA-based and Targeted Oncology Candidates at AACR 2024
Lunes 11 de Marzo 2024 (1 mes hace) • GlobeNewswire Inc.

The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of March 12, 2024 in BioNTech Lawsuit - BNTX
Lunes 11 de Marzo 2024 (1 mes hace) • PR Newswire (US)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Jueves 7 de Marzo 2024 (1 mes hace) • Edgar (US Regulatory)

BioNTech Announces Planned Retirement of Sean Marett
Jueves 7 de Marzo 2024 (1 mes hace) • GlobeNewswire Inc.

BioNTech to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Corporate Update on March 20, 2024
Miércoles 6 de Marzo 2024 (1 mes hace) • GlobeNewswire Inc.

The Gross Law Firm Reminds BioNTech SE Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 12, 2024 - BNTX
Martes 5 de Marzo 2024 (1 mes hace) • PR Newswire (US)

Más de BioNTech SE Artículos de Noticias

Euro vs US Dollar

JP Morgan Chase

Invesco QQQ Trust Series 1

Deutsche Telekom (QX)

Financial Select Sector

Energy Select Sector SPDR

Delayed Upgrade Clock

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones